UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay

SLAS discovery, 2016-08, Vol.21 (7), p.701-712

2016

Volltextzugriff (PDF)

Convergent, Discriminant, and Concurrent Validity of Nonmemory-Based Performance Validity Tests

Assessment (Odessa, Fla.), 2020-10, Vol.27 (7), p.1399-1415

2020

Volltextzugriff (PDF)

Where there is inflammation, treatment may reduce disability progression – No

Multiple sclerosis, 2018-12, Vol.24 (14), p.1810-1812

2018

Volltextzugriff (PDF)

Treating active MS following induction therapies

Multiple sclerosis, 2022, Vol.28 (3_SUPPL), p.38-38

2022

Volltextzugriff (PDF)

Reframing Part-Work Pedagogy: Three Portraits

Journal of General Music Education, 2023-10, Vol.37 (1), p.20-25

Dillon, Jonathan Edan

2023

Volltextzugriff (PDF)

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Multiple sclerosis, 2022-07, Vol.28 (8), p.1277-1285

2022

Volltextzugriff (PDF)

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

Multiple sclerosis, 2011-07, Vol.17 (7), p.867-875

2011

Volltextzugriff (PDF)

Cumulative effects of therapies on disability in relapsing multiple sclerosis

Multiple sclerosis, 2021-10, Vol.27 (11), p.1760-1770

2021

Volltextzugriff (PDF)

There is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes

Multiple sclerosis, 2012-07, Vol.18 (7), p.927-929

Edan, Gilles

2012

Volltextzugriff (PDF)

Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study

Multiple sclerosis, 2023-05, Vol.29 (6), p.719-730

2023

Volltextzugriff (PDF)

Oral rather than intravenous corticosteroids should be used to treat MS relapses – Yes

Multiple sclerosis, 2017-07, Vol.23 (8), p.1056-1058

2017

Volltextzugriff (PDF)

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Multiple sclerosis, 2020-07, Vol.26 (8), p.924-935

2020

Volltextzugriff (PDF)

Richard E Gonsette (1929–2014)

Multiple sclerosis, 2015-04, Vol.21 (5), p.540-540

2015

Volltextzugriff (PDF)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Multiple sclerosis, 2016-11, Vol.22 (13), p.1719-1731

2016

Volltextzugriff (PDF)

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients

Multiple sclerosis, 2017-05, Vol.23 (6), p.864-871

2017

Volltextzugriff (PDF)

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

Multiple sclerosis, 2021-03, Vol.27 (3), p.479-482

2021

Volltextzugriff (PDF)

Optimization and analysis of Sic reinforced copolymer blend composite structural springs

Proceedings of the Institution of Mechanical Engineers. Part E, Journal of process mechanical engineering, 2023-12

2023

Volltextzugriff (PDF)

Pediatric Primary Care Provider Perspectives on Universal Suicide Screening

Journal of primary care & community health, 2024-01, Vol.15, p.21501319241271321

2024

Volltextzugriff (PDF)

High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice

Multiple sclerosis, 2020-12, Vol.26 (14), p.1898-1906

2020

Volltextzugriff (PDF)

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Multiple sclerosis, 2016-04, Vol.22 (4), p.533-543

2016

Volltextzugriff (PDF)

Deciphering multiple sclerosis disability progression in the elderly: a multicenter cohort study

Multiple sclerosis, 2022, Vol.28 (3_SUPPL), p.450-450

2022

Volltextzugriff (PDF)

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

Multiple sclerosis, 2021-01, Vol.27 (1), p.90-96

2021

Volltextzugriff (PDF)

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

Journal of evidence-based integrative medicine, 2018-01, Vol.23, p.2515690X18806269-2515690X18806269

2018

Volltextzugriff (PDF)

La Chronologie Des Haches Polies Dites De Prestige Edans La Moitie Ouest De La France

European journal of archaeology, 1999-04, Vol.2 (1), p.7-33

Cassen, S.

1999

Volltextzugriff (PDF)

Discontinuation of high- versus middle-efficacy disease-modifying treatment in middle-aged patients with multiple sclerosis

Multiple sclerosis, 2022, Vol.28 (3_SUPPL), p.911-912

2022

Volltextzugriff (PDF)

1 – 25 von 902

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

KollektionSAGE Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(893)
Mit Volltextzugriff
(878)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay

Convergent, Discriminant, and Concurrent Validity of Nonmemory-Based Performance Validity Tests

Where there is inflammation, treatment may reduce disability progression – No

Treating active MS following induction therapies

Reframing Part-Work Pedagogy: Three Portraits

Body mass index as a predictor of MS activity and progression among participants in BENEFIT

Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study

Cumulative effects of therapies on disability in relapsing multiple sclerosis

There is no such thing as a mild MS relapse. The mild relapse is an Anglo-Saxon delusion - Yes

Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study

Oral rather than intravenous corticosteroids should be used to treat MS relapses – Yes

Decreasing impact of late relapses on disability worsening in secondary progressive multiple sclerosis

Richard E Gonsette (1929–2014)

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients

The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

Optimization and analysis of Sic reinforced copolymer blend composite structural springs

Pediatric Primary Care Provider Perspectives on Universal Suicide Screening

High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis

Deciphering multiple sclerosis disability progression in the elderly: a multicenter cohort study

Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries

Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes

La Chronologie Des Haches Polies Dites De Prestige Edans La Moitie Ouest De La France

Discontinuation of high- versus middle-efficacy disease-modifying treatment in middle-aged patients with multiple sclerosis

Aktive Filter

Suchergebnisse filtern